GlassScriptPhysician profile
Whitney Rowe
NPI 1902395528
$1,220.98
in general payments reported to CMS, 2019-2025
11 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $168 · 2023: $391 · 2024: $346 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $681.46 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Exeltis, USA INC. | $162.75 | 2023-2025 | Slynd |
| Novo Nordisk INC | $111.03 | 2021-2025 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $69.95 | 2023-2024 | Veozah |
| Lilly USA, LLC | $64.76 | 2023-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $51.70 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Becton, Dickinson and Company | $18.71 | 2023 | Bd Surepath Collection Vial |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.60 | 2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $15.42 | 2023 | Gattex |
| Nestle Healthcare Nutrition INC. | $14.49 | 2023 | |
| Gynesonics, INC. | $14.11 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.